Staged Diabetes Management: A Systematic Approach, 2nd Edition

by Roger Mazze (International Diabetes Center, USA); Ellie S. Strock (International Diabetes Center, USA); Gregg Simonson (International Diabetes Center, USA); Richard M. Bergenstal (International Diabetes Center, USA)

• ISBN13: 9780470865767
• ISBN10: 0470865768
• Edition: 2nd
• Format: Hardcover
• Copyright: 2004-06-01
• Publisher: WILEY

Summary

Staged Diabetes Management continues the four-decade tradition of the International Diabetes Center by providing clinical pathways that improve care practices. SDM uses evidence-based medicine to address the prominent issues of primary care diabetes management. It supplies practical solutions to the detection and treatment of diabetes, its complications and such new areas as the metabolic syndrome, pre-diabetes and type 2 diabetes in children. Completely revised and updated, the text reviews the fundamental basis of diabetes management and then addresses treatment of each type of diabetes and the major micro- and macrovascular complications. Written for primary care, it is organised in such a manner as to allow the clinician to learn about each distinctive type of diabetes as well as to see the areas of overlap. Issues range from classification, screening and detection to starting a therapy and long-term management of hypertension complicated by diabetes. Educational, nutritional and behavioural issues are also covered. Using DecisionPaths as a way to organise clinical decision-making, each chapter can stand alone, yet they are integrated (as is clinical practice). Each DecisionPath is structured so that therapies can be started, adjusted and maintained. Each decision point is clarified in the text along with the scientific basis for the decision.

Author Biography

Mazze, Strock, Simonson, Bergenstal International Diabetes Center

Table of Contents

About the Authors	p. xi
Acknowledgments	p. xiii
Staged Diabetes Management in Practice	p. 1
Introduction to Staged Diabetes Management	p. 3
The development of staged diabetes management	p. 4
The structure of staged diabetes management	p. 6
Practice guidelines	p. 8
Master DecisionPaths	p. 10
Specific DecisionPaths	p. 12
Criteria for adjusting and changing therapy	p. 14
Diabetes management assessment DecisionPaths	p. 15
The patient and staged diabetes management	p. 17
The diabetes care team	p. 18
The changing perspective of diabetes care: DCCT and UKPDS	p. 19
Metabolic syndrome (insulin resistance syndrome)	p. 22
Children and adolescents with type 2 diabetes and/or metabolic syndrome	p. 22
Common diagnostic criteria	p. 23
Diabetes management improvement initiatives	p. 24
References	p. 25
The Implementation of Staged Diabetes Management	p. 27
Community diabetes care needs assessment	p. 28
Orientation to staged diabetes management	p. 34
Customization of staged diabetes management	p. 35
Evaluation of staged diabetes management	p. 45
References	p. 48
Therapeutic Principles for the Treatment of Diabetes	p. 49
Medical nutrition therapy stage	p. 49
Oral agent stage	p. 50
Insulin stage	p. 56
Combination therapies	p. 64
Evaluating blood glucose control	p. 64
References	p. 74
The Treatment of Diabetes	p. 77
Type 2 Diabetes	p. 79
Etiology	p. 79
Overview of treatment options for type 2 diabetes	p. 83
The impact of the DCCT, UKPDS, and other major studies	p. 84
Prevention of type 2 diabetes	p. 85
Type 2 diabetes detection and treatment	p. 86
Type 2 diabetes practice guidelines	p. 87
Type 2 diabetes Master DecisionPath	p. 97
New treatment alternatives	p. 136
Management of acute complications	p. 139
Type 2 diabetes and pregnancy	p. 142
Patient education	p. 143
Behavioral issues and assessment	p. 146
References	p. 150
Type 2 Diabetes and Metabolic Syndrome in Children and Adolescents	p. 153
Etiology	p. 154
Prevention of type 2 diabetes	p. 155
Major studies	p. 155
Overview of treatment options for children and adolescents with type 2 diabetes	p. 156
Obesity and weight management in children and adolescents	p. 157
Type 2 diabetes in children and adolescents	p. 165
Metabolic syndrome in children and adolescents	p. 195
References	p. 214
Type 1 Diabetes	p. 215
Etiology	p. 215
Type 1 diabetes detection and treatment	p. 216
Type 1 diabetes practice guidelines	p. 217
Screening and diagnosis DecisionPath	p. 222
Type 1 diabetes Master DecisonPath	p. 223
Management of acute complications	p. 239
Type 1 diabetes and pregnancy	p. 241
Patient education	p. 244
Behavioral issues and assessment	p. 251
References	p. 257
Pregestational and Gestational Diabetes	p. 259
Etiology of GDM and hyperglycemia	p. 260
Adverse fetal and perinatal outcome	p. 261
Preventing gestational diabetes and subsequent type 2 diabetes	p. 261
Pregestational diabetes	p. 262
Gestational diabetes detection and treatment	p. 264
Gestational diabetes practice guidelines	p. 264
Gestational diabetes Master DecisionPath	p. 270
Pregestational (type 1 and type 2) diabetes treatment options	p. 289
Fetal and maternal assessment	p. 290
References	p. 294
Insulin Resistance and Diabetes Complications	p. 297
Macrovascular Disease	p. 299
Diabetes and the risk of cardiovascular disease	p. 299
Role of inflammation in cardiovascular disease	p. 300
Prevention of cardiovascular disease in diabetes: importance of multifactorial approach	p. 301
Insulin resistance, hypertension, and cardiovascular disease	p. 301
Detection and treatment of hyperglycemia, hypertension, and dyslipidemia	p. 303
Practice guidelines: hypertension and dyslipidemia	p. 304
Staged management of hypertension	p. 305
Staged management of hyperlipidemia and dyslipidemia	p. 312
Additional therapeutic options for prevention and treatment of cardiovascular disease	p. 318
References	p. 320
Microvascular Complications	p. 323
Detection and treatment of diabetic nephropathy	p. 323
Detection and treatment of eye complications	p. 331
Detection and treatment of diabetic neuropathy	p. 342
Detection and treatment of foot complications	p. 353
Detection and treatment of dermatological, connective tissue, and oral complications	p. 366
Polycystic ovary syndrome (PCOS)	p. 369
References	p. 370
Hospitalization	p. 375
The current impact of diabetes related hospitalizations	p. 375
Hospitalization practice guidelines	p. 376
Hospitalization for problems related to glycemic control	p. 377
Hospitalization for illness	p. 384
Hospitalization for surgery	p. 386
References	p. 389
Appendix	p. 391
Index	p. 427
Table of Contents provided by Rittenhouse. All Rights Reserved.